Healthy Extracts president and COO resigns

Healthy Extracts Inc. reported a leadership change.

(Moderate)

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

Healthy Extracts Inc. reported a leadership change. On July 1, 2026, Kevin “Duke” Pitts resigned as President, Chief Operating Officer, and as a member of the Board of Directors. The company stated that the positions of President and Chief Operating Officer will remain vacant until further notice.

Positive

None.

Negative

Multi-role leadership departure: Kevin “Duke” Pitts resigned as President, Chief Operating Officer, and director effective July 1, 2026, leaving both executive roles vacant until further notice and potentially increasing near-term governance and operational uncertainty.

Insights

Healthy Extracts faces a multi-role executive and board departure that may weigh on governance stability.

The company disclosed that Kevin “Duke” Pitts resigned as President, Chief Operating Officer, and director effective July 1, 2026. These are key operational and oversight roles, so his departure concentrates responsibility among remaining leaders and directors.

The positions of President and Chief Operating Officer will remain vacant until further notice, which may leave day-to-day operations and strategic execution more dependent on the CEO and remaining management. Future company filings may clarify succession plans and any new appointments to these roles or the board.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Key Figures

Resignation effective date: July 1, 2026 Filing signature date: July 6, 2026 Vacant executive roles: 2 roles

3 metrics

Resignation effective date July 1, 2026 Kevin “Duke” Pitts leaves President, COO, and director roles

Filing signature date July 6, 2026 8-K signed by CEO Donald Swanson

Vacant executive roles 2 roles President and Chief Operating Officer to remain vacant

Key Terms

Emerging growth company, Section 5 – Corporate Governance and Management, Item 5.02, Board of Directors

4 terms

Emerging growth company regulatory

"Emerging growth company Section 5 – Corporate Governance and Management"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Section 5 – Corporate Governance and Management regulatory

"Section 5 – Corporate Governance and Management Item 5.02Departure of Directors"

Item 5.02 regulatory

"Item 5.02Departure of Directors or Certain Officers; Election of Directors"

Board of Directors financial

"and as a member of our Board of Directors."

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

FAQ

What leadership change did Healthy Extracts Inc. (HYEX) disclose in this 8-K?

Healthy Extracts Inc. disclosed that Kevin “Duke” Pitts resigned as President, Chief Operating Officer, and board member effective July 1, 2026. This removes a key executive overseeing operations and strategy, and also changes the composition of the company’s Board of Directors.

When did Kevin “Duke” Pitts resign from Healthy Extracts Inc. (HYEX)?

Kevin “Duke” Pitts resigned from Healthy Extracts Inc. effective July 1, 2026. The filing states his resignation covered three roles: President, Chief Operating Officer, and member of the Board of Directors, marking a significant leadership and governance change on that date.

Which positions are currently vacant at Healthy Extracts Inc. (HYEX)?

Healthy Extracts Inc. stated that the positions of President and Chief Operating Officer will remain vacant until further notice. These roles were previously held by Kevin “Duke” Pitts before his July 1, 2026 resignation from the company and its Board of Directors.

Does the Healthy Extracts Inc. (HYEX) filing mention changes to the Board of Directors?

Yes, the filing notes that Kevin “Duke” Pitts resigned as a member of the Board of Directors on July 1, 2026. This reduces the board’s membership and removes an executive voice from the company’s governance structure at the same time as his management departure.

Who signed the Healthy Extracts Inc. (HYEX) 8-K reporting this resignation?

The 8-K was signed on behalf of Healthy Extracts Inc. by Donald Swanson as Chief Executive Officer. His signature indicates the company’s formal acknowledgment of Kevin “Duke” Pitts’ resignation and the decision to leave the President and COO positions vacant until further notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 07/06/2026 - 04:01 PM Accepted by SEC EDGAR 07/06/2026 - 04:01 PM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

July 1, 2026

HEALTHY EXTRACTS INC.

(Exact name of registrant as specified in its charter)

Nevada	000-55572	47-2594704
(State or other	(Commission	(I.R.S. Employer
jurisdiction of incorporation)	File Number)	Identification No.)

7375 Commercial Way, Suite 125
Henderson, NV 89011
(Address of principal executive offices) (zip code)

(702) 463-1004
(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Section 5 – Corporate Governance and Management

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On July 1st, 2026, Kevin “Duke” Pitts resigned as our President, Chief Operating Officer, and as a member of our Board of Directors.

The position of President and Chief Operating Officer will remain vacant until further notice.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Healthy Extracts Inc.


Dated: July 6, 2026	/s/ Donald Swanson
	`By:`Donald Swanson
	`Its:`Chief Executive Officer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

4 documents